Published on Global Research Projects (https://globalprojects.ucsf.edu)

Home > VX11-950-115 An Open Label, Phase 3 Study of Telaprevir in Combination With Peginterferon Alfa 2a (Pegasys®) and Ribavirin (Copegus®) in Subjects Coinfected With Genotype 1 Hepatitis C Virus and Human Immunodeficiency Virus Type 1(HCV/HIV-1)

VX11-950-115 An Open Label, Phase 3 Study of Telaprevir in Combination With Peginterferon Alfa 2a (Pegasys®) and Ribavirin (Copegus®) in Subjects Coinfected With Genotype 1 Hepatitis C Virus and Human Immunodeficiency Virus Type 1(HCV/HIV-1)

© 2019 The Regents of the University of California
Source URL: https://globalprojects.ucsf.edu/project/vx11-950-115-open-label-phase-3-study-telaprevir-combination-peginterferon-alfa-2a-pegasys%C2%AE